Controlled Clinical TrialtaVNS

Feasibility and acceptance of transdermal auricular vagus nerve stimulation using a TENS device in females suffering from long COVID fatigue

Pfoser-Poschacher V, Keilani M, Steiner M, Schmeckenbecher J, Zwick RH, Crevenna R

Wiener klinische Wochenschrift · 2025

Key finding

The study revealed that all VNS treatment groups experienced reduction in symptoms associated with long COVID, particularly in fatigue and dyspnea, after 12 weeks.

Condition
Long COVID
Stimulation
taVNS
Evidence tier
Controlled Clinical Trial
Participants
View on DOI

Cite this study

Pfoser-Poschacher, V., Keilani, M., Steiner, M., Schmeckenbecher, J., Zwick, R. H., & Crevenna, R. (2025). Feasibility and acceptance of transdermal auricular vagus nerve stimulation using a TENS device in females suffering from long COVID fatigue. Wiener klinische Wochenschrift, 137(19-20), 635-641. https://doi.org/10.1007/s00508-025-02501-1

Related studies in Long COVID

Summary by Vagus Research. Always consult the primary source for the authoritative record.

Stay Current with the Research

Join researchers and practitioners exploring the science of vagus nerve stimulation. Receive curated research summaries and evidence updates.

No spam. Unsubscribe at any time. We respect your privacy.